Skip to main content
. 2020 Mar 27;21(7):2319. doi: 10.3390/ijms21072319
AD Alzheimer’s disease
CNS Central nervous system
COX-2 Cyclooxygenase-2
ERK1/2 Extracellular signal-regulated kinase 1/2
IκBs Inhibitors of kappa B
IL Interleukin
iNOS Inducible nitric oxide synthase
JNK C-Jun N-terminal kinase
LPS Lipopolysaccharide
MAPK Mitogen-activated protein kinase
NF-κB Nuclear factor-kappa B
NO Nitric oxide
PD Parkinson’s disease
TLR Toll-like receptor
TNF-α Tumor necrosis factor-alpha